壮医药线点灸治疗血管性痴呆的临床效果

摘要
图/表
参考文献(19)
相关文章 (15)

全文: PDF (0 KB) HTML (40 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨壮医药线点灸治疗血管性痴呆的临床效果。方法选取2016年2月～2019年7月我院收治的60例血管性痴呆患者作为研究对象，按照随机数字表法将其分为治疗组（30 例）和对照组（30 例）。治疗组患者在基础治疗之外接受壮医药线点灸治疗，对照组患者在基础治疗之外接受吡拉西坦片治疗。两组患者治疗期均为30 d。比较两组患者的临床疗效、简易智力状态检查量表（MMSE）、Barthel 指数评定量表（Barthel）及美国国立卫生研究院卒中量表（NIHSS）评分的变化。结果治疗组患者治疗后的MMSE 评分总有效率为86.67%，高于对照组的63.33%，差异有统计学意义（P＜0.05）；治疗组患者治疗后NIHSS 评分总有效率为90.00%，高于对照组的66.67%，差异有统计学意义（P＜0.05）。治疗后，两组患者的MMSE、Barthel 评分均高于治疗前，NIHSS 评分低于治疗前，差异有统计学意义（P＜0.05）；治疗组患者治疗后的MMSE、Barthel 评分高于对照组，NIHSS 评分低于对照组，差异有统计学意义（P＜0.05）。结论壮医药线点灸治疗可有效改善血管性痴呆患者的认知功能和行为能力，降低患者的神经功能缺损程度，值得临床应用及推广。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	韦羡萍
	林佳明
	林利城
	吴艳丽

关键词 ：壮医药线点灸, 血管性痴呆, 认知障碍, 神经功能缺损

Abstract：Objective To investigate the clinical effect of Zhuang medical thread moxibustion in the treatment of vascular dementia. Methods A total of 60 patients with vascular dementia who treated in our hospital from February 2016 to July 2016 were selected as subjects. The patients were divided into treatment group (30 cases) and control group(30 cases) on the basis of random number table method. Patients in the treatment group were treated with Zhuang medical thread moxibustion on the basic treatment, while the patients in the control group were treated with Piracetam Tablets, 30 days were a course of treatment. The treatment effect, score changes of mini mental state examination(MMSE), the Barthel index of ADL (Barthel) and the National Institutes of Health stroke scale (NIHSS) of the two groups were compared. Results The total effective rate of the score of MMSE in the treatment group was 86.67% after treatment, which was higher than 63.33% of the control group, and the difference was statistically significant (P＜0.05). The total effective rate of the score of NIHSS in the treatment group (90.00%) was higher than that in the control group(66.67%), and the difference was statistically significant (P＜0.05). After treatment, the MMSE and Barthel scores of the two groups were higher than those before treatment, and the NIHSS scores were lower than those before treatment, the differences were statistically significant (P＜0.05). The scores of MMSE and Barthel in the treatment group were higher than those of the control group, while NIHSS score was lower than that of the control group, with significant differences(P＜0.05). Conclusion Zhuang medical thread moxibustion can effectively improve the cognitive function and behavior ability of patients and reduce neurological deficit. It is worthy of clinical application and promotion.

Key words： Zhuang medical thread moxibustion Vascular dementia Cognitive disorders Neurological deficit

基金资助:广西壮族自治区卫生和计划生育委员会中医药科技专项（GZLC16-74）

作者简介: 韦羡萍（1980-），女，广西柳江人，硕士，副主任医师，研究方向：脑血管疾病的中西医结合防治

引用本文:

韦羡萍; 林佳明; 林利城; 吴艳丽. 壮医药线点灸治疗血管性痴呆的临床效果[J]. 中国当代医药, 2020, 27(16): 182-185.
WEI Xian-ping; LIN Jia-ming; LIN Li-cheng; WU Yan-li. Clinical effect of Zhuang medical thread moxibustion in the treatment of vascular dementia. 中国当代医药, 2020, 27(16): 182-185.

链接本文:

http://dangdaiyiyao.com/CN/ 或 http://dangdaiyiyao.com/CN/Y2020/V27/I16/182

[1]	王维治.神经病学[M].北京：人民卫生出版社，2006：1414.
[2]	Wolters FJ，Ikram MA.Epidemiology of vascular dementia：nosology in a time of epiomics[J].Arterioscler Thromb Vasc Biol，2019，39（8）：1542-1549.
[3]	Poli L，De Giuli V，Piazza F，et al.A challenging diagnosis of reversible“vascular”dementia：Cerebral amyloid angiopathyrelated inflammation[J].J Neuroimmunol，2020，338：577 109.
[4]	李经伟，孙世杰，郑攀.中医药治疗血管性痴呆研究进展[J].中国民间疗法，2020，28（3）：93-96.
[5]	邵亚兰，郑露茜，杨树龙.血管性痴呆的中医药治疗新进展[J].中国医药导报，2019，16（21）：39-42.
[6]	American Psychiatric Association.Diagnostic and statistical manual of mental disorders （DSM-IV）[M].4thed.Washington DC：Am Psychiat Assoc，1994：143-147.
[8]	Morris JC.The clinical dementia rating（CDR）：Current version and scoring rules[J].Neurology，1993，43：2412-2414.
[9]	中华人民共和国卫生部.中药新药临床研究指导原则（2 辑）[S].北京：中华人民共和国卫生部，1995：206.
[10]	田金州，韩明向，涂晋文，等.血管性痴呆诊断、辨证及疗效判定标准（研究用）[J].中国老年学杂志，2002，22（9）：329-331.
[11]	中华神经科杂志编辑部.各类脑血管疾病诊断要点[J].中华神经科杂志，1996，29（6）：379.
[12]	吴勉华，王新月.中医内科学[M].3 版.北京：中国中医药出版社，2012.
[7]	Roman GC，Tatemichi TK，Erkinjuntti T，et al.Vascular dementia：Diagnostic criteria for research studies.Report of the NINDS-AIREN international workshop[J].Neurology，1993，43（2）：250-260.
[13]	覃辉，陆晖，周诚恩.活血化瘀补肾法联合针刺对血管性痴呆患者认知功能及血清IL-18、IFN-γ 水平影响[J].世界中西医结合杂志，2018，13（10）：22-25.
[14]	Azarpazhooh MR，Hachinski V.Vascular cognitive impairment：A preventable component of dementia[J].Handb Clin Neurol，2019，167：377-391.
[15]	Nordestgaard LT，Christoffersen M，Afzal S，et al.Loss-offunction mutations in Abca1，HDL-cholesterol，metabolomic profiles and risk of vascular disease and dementia -a cohort study of up to 100，000 individuals[J].Atherosclerosis，2019，287：e106-e107.
[16]	Shuko Takeda，Hiromi Rakugi，Ryuichi Morishita.Roles of vascular risk factors in the pathogenesis of dementia[J].Hypertens Res，2020，43（3）：162-167.
[17]	余九峰，黄贵华，李婕，等.壮医药线点灸合普通针刺治疗中风后遗症40 例疗效观察[J].湖南中医杂志，2014，30（2）：67-70.
[18]	古联，陈清，谢娟娟.急性脑卒中患者的早期壮医药线点灸法结合康复治疗[J].中国老年学杂志，2013，33（2）：258-260.
[19]	梁振兴.壮医药线点灸辅治中风后吞咽困难42 例观察[J].实用中医药杂志，2015，31（8）：738-739.